Prelude Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,500
| Closed | -$48.3K | – | 1293 |
|
|
2025
Q1 | $48.3K | Buy |
+17,500
| New | +$48.3K | ﹤0.01% | 1005 |
|
|
2024
Q4 | – | Sell |
-18,778
| Closed | -$157K | – | 1437 |
|
|
2024
Q3 | $157K | Sell |
18,778
-13,309
| -41% | -$111K | 0.01% | 997 |
|
|
2024
Q2 | $219K | Sell |
32,087
-52,532
| -62% | -$358K | 0.02% | 857 |
|
|
2024
Q1 | $555K | Buy |
+84,619
| New | +$555K | 0.03% | 527 |
|
|
2022
Q4 | – | Sell |
-10,945
| Closed | -$64K | – | 1480 |
|
|
2022
Q3 | $64K | Buy |
+10,945
| New | +$64K | ﹤0.01% | 1173 |
|